Hematopoietic and Endothelial Differentiation of Human Induced Pluripotent Stem Cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Stem Cells

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1634/stemcells.2008-0922PMID 19259936PMCID PMC2931800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells

  2008cited by this paper
• Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors.

  2008cited by this paper
• Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages

  2008cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated Without Viral Integration

  2008cited by this paper
• Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

  2008cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin

  2007cited by this paper
• In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Hematoendothelial Differentiation of Human Embryonic Stem Cells

  2007cited by this paper
• Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.

  2007cited by this paper
• Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

  2007cited by this paper
• Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures.

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells through the Myeloid Pathway1

  2006cited by this paper
• T lineage differentiation from human embryonic stem cells.

  2006cited by this paper
• Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development.

  2005cited by this paper
• Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function

  2005cited by this paper
• Human Embryonic Stem Cell-Derived NK Cells Acquire Functional Receptors and Cytolytic Activity1

  2005cited by this paper
• Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

  2005cited by this paper
• Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development.

  2005cited by this paper
• Biochemical and genetic analysis of the Oka blood group antigen

  2004cited by this paper
• The in vitro production and characterization of neutrophils from embryonic stem cells.

  2004cited by this paper
• Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro

  2004cited by this paper
• Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells.

  2003cited by this paper
• Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling

  2002cited by this paper
• Directed differentiation of dendritic cells from mouse embryonic stem cells.

  2000cited by this paper
• Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.

  2000cited by this paper
• Functional characterization of B lymphocytes generated in vitro from embryonic stem cells.

  1999cited by this paper
• Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages.

  1998cited by this paper
• In Vitro Development of Primitive and Definitive Erythrocytes from Different Precursors

  1996cited by this paper
• Hematopoietic commitment during embryonic stem cell differentiation in culture.

  1993cited by this paper

• Harnessing intermediate-scale bioreactors for next-generation macrophage production and application.

  2026cites this paper
• Discovery of a chemical small molecule inducing umbilical cord mesenchymal stem cell differentiation to vascular endothelial cells

  2026cites this paper
• Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy.

  2026cites this paper
• Integrating Macrophages into Human-Engineered Cardiac Tissue

  2025cites this paper
• Adipose-Derived Stem Cell-Loaded Fish-GelMA/CMC Hydrogel Accelerates Wound Healing via Macrophage Polarization Suppression and Promoting Angiogenesis.

  2025cites this paper
• Hematopoietic stem cells and HSCs-derived from pluripotent stem cells: a hopeful outlook in cell-based therapeutics

  2025cites this paper
• Non-integrating direct reprogramming generates therapeutic endothelial cells with sustained vascular regeneration capacity enhanced by nanomatrix delivery

  2025cites this paper
• Fibroblast-Derived Human iPSC Exhibits Superior Haematopoietic Potential over Human ESC during Haematopoietic Differentiation

  2025cites this paper
• Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells.

  2025cites this paper
• The eve of a historic breakthrough in the realm of human pluripotent stem cell-derived haematopoietic stem cells

  2025cites this paper
• Post-myocardial Infarction Cardiac Remodeling: Multidimensional Mechanisms and Clinical Prospects of Stem Cell Therapy

  2025cites this paper
• Discovery platforms for RNA therapeutics

  2024cites this paper
• In vitro erythropoiesis: the emerging potential of induced pluripotent stem cells (iPSCs)

  2024cites this paper
• Tissue‐Engineered Microvessels: A Review of Current Engineering Strategies and Applications

  2024cites this paper
• Understanding genomic medicine for thoracic aortic disease through the lens of induced pluripotent stem cells

  2024cites this paper
• Manufacturing CAR-NK against tumors: Who is the ideal supplier?

  2024cites this paper
• Prostate cancer research: tools, cell types, and molecular targets

  2024cites this paper
• Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells

  2024cites this paper
• Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy

  2024cites this paper
• Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease

  2024cites this paper
• STAMP: Single-cell transcriptomics analysis and multimodal profiling through imaging

  2024cites this paper
• Synergy between pluripotent stem cell‐derived macrophages and self‐renewing macrophages: Envisioning a promising avenue for the modelling and cell therapy of infectious diseases

  2024cites this paper
• Recent advances in cell-based in vitro models for predicting drug permeability across brain, intestinal, and pulmonary barriers

  2024cites this paper
• Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges

  2024cites this paper
• Forward programming of hiPSCs via the transcription factor ETV2: rapid, reproducible, and cost-effective generation of highly enriched, functional endothelial cells.

  2024cites this paper
• Resident vascular Sca1+ progenitors differentiate into endothelial cells in vascular remodeling via miR-145-5p/ERG signaling pathway

  2024cites this paper
• Smart Cell Therapy: an industry perspective on macrophages as living drugs.

  2024cites this paper
• A guide for blood–brain barrier models

  2024cites this paper
• SOX18-enforced expression diverts hemogenic endothelium-derived progenitors from T towards NK lymphoid pathways

  2023cites this paper
• p53 Activation Facilitates Transdifferentiation of Human Cardiac Fibroblasts into Endothelial Cells

  2023cites this paper
• ‘Off the shelf’ immunotherapies: Generation and application of pluripotent stem cell‐derived immune cells

  2023cites this paper
• Recent updates of stem cell-based erythropoiesis

  2023cites this paper
• Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?

  2023cites this paper
• Human Endometrium Derived Induced Pluripotent Stem Cells Are Amenable to Directed Erythroid Differentiation

  2023cites this paper
• From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic cardiomyopathies

  2023cites this paper
• Experimental Models to Study the Functions of the Blood–Brain Barrier

  2023cites this paper
• Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives

  2023cites this paper
• De Novo Generation of Human Hematopoietic Stem Cells from Pluripotent Stem Cells for Cellular Therapy

  2023cites this paper
• Current Progress in Vascular Engineering and Its Clinical Applications

  2022cites this paper
• Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease

  2022cites this paper
• Macrophages derived from pluripotent stem cells: prospective applications and research gaps

  2022cites this paper
• Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor

  2022cites this paper
• Induced pluripotent stem cells–derived hematopoietic progenitors for cellular immunotherapies

  2022cites this paper
• Erythroid Differentiation of Induced Pluripotent Stem Cells Co-cultured with OP9 Cells for Diagnostic Purposes

  2022cites this paper
• Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor

  2022cites this paper
• iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories

  2022cites this paper
• 3D Human iPSC Blood Vessel Organoids as a Source of Flow‐Adaptive Vascular Cells for Creating a Human‐Relevant 3D‐Scaffold Based Macrovessel Model

  2022cites this paper
• “Cutting the Mustard” with Induced Pluripotent Stem Cells: An Overview and Applications in Healthcare Paradigm

  2022cites this paper
• Strategies for Regenerative Vascular Tissue Engineering

  2022cites this paper
• PEAR1 is a potential regulator of early hematopoiesis of human pluripotent stem cells

  2022cites this paper
• Derivation and Characterization of Endothelial Cells from Porcine Induced Pluripotent Stem Cells

  2022cites this paper
• The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling

  2022cites this paper
• Overexpression of HOXA9 upregulates NF-κB signaling to promote human hematopoiesis and alter the hematopoietic differentiation potentials

  2021cites this paper
• Applicability of organ-on-chip systems in toxicology and pharmacology

  2021cites this paper
• Microvascular Networks and Models: In Vitro Formation

  2021cites this paper
• Modeling Transposition of the Great Arteries with Patient-Specific Induced Pluripotent Stem Cells

  2021cites this paper
• Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions

  2021cites this paper
• Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies

  2021cites this paper
• Directed Differentiation of Human Pluripotent Stem Cells toward Skeletal Myogenic Progenitors and Their Purification Using Surface Markers

  2021cites this paper
• Modeling the cardiovascular toxicities of anticancer therapies in the era of precision medicine

  2021cites this paper
• Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies

  2021cites this paper
• Types and Classification of Stem Cells

  2021cites this paper
• Industrially Compatible Transfusable iPSC-Derived RBCs: Progress, Challenges and Prospective Solutions

  2021cites this paper
• A 3-D hydrogel based system for hematopoietic differentiation and its use in modeling down syndrome associated transient myeloproliferative disorder.

  2021cites this paper
• Advances in pluripotent stem cell-derived natural killer cells for cancer immunotherapy

  2021cites this paper
• A New Induction Method for the Controlled Differentiation of Human-Induced Pluripotent Stem Cells Using Frozen Sections

  2021cites this paper
• Generation of platelets with enhanced functionality by targeting transgenic proteins to alpha granules in megakaryocytes

  2021cites this paper
• Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells

  2021cites this paper
• iPSC-derived erythroid cells

  2021cites this paper
• Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions

  2021cites this paper
• Regulation of endothelial cell differentiation in embryonic vascular development and its therapeutic potential in cardiovascular diseases.

  2021cites this paper
• In vitro and in vivo study on angiogenesis of porcine induced pluripotent stem cell-derived endothelial cells.

  2021cites this paper
• Engineering Human Cardiac Muscle Patch Constructs for Prevention of Post-infarction LV Remodeling

  2021influential citation
• Blood Pharming – eine realistische Option?

  2021cites this paper
• Specificity of Organoids for Precision Tissue Regeneration: A Review

  2021cites this paper
• Human pluripotent stem cells: An alternative for 3D in vitro modelling of skin disease

  2021cites this paper
• Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids

  2021cites this paper
• Differentiation of human induced pluripotent stem cells into erythroid cells

  2020cites this paper
• Blood components from pluripotent stem cells

  2020cites this paper
• Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.

  2020cites this paper
• Using Eukaryotic Expression Systems to Generate Human α1,3 Fucosyltransferases that Effectively Create Selectin-binding Glycans on Stem Cells.

  2020cites this paper
• Pluripotent stem cell model of Shwachman–Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors

  2020cites this paper
• iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine

  2020cites this paper
• Generation of T cells from Human and Nonhuman Primate Pluripotent Stem Cells.

  2020cites this paper
• Coadministration of endothelial and smooth muscle cells derived from human induced pluripotent stem cells as a therapy for critical limb ischemia

  2020cites this paper
• Biomaterials for Bioprinting Microvasculature.

  2020cites this paper
• Stem Cell Dynamics and Cytoceuticals for Therapeutics and Toxicity Screening: A Review

  2020cites this paper
• Small-molecule-mediated reprogramming: a silver lining for regenerative medicine

  2020cites this paper
• Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

  2020influential citation
• Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors

  2020cites this paper
• Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium

  2020cites this paper
• Machine learning uncovers cell identity regulator by histone code

  2020cites this paper
• Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders

  2019cites this paper
• From embryonic stem cells to induced pluripotent stem cells—Ready for clinical therapy?

  2019cites this paper
• Engineering of Pulmonary Microvasculature forWhole Lung Engineering

  2019cites this paper
• Derivation of primitive neural stem cells from human‐induced pluripotent stem cells

  2019cites this paper
• DKK3 (Dikkopf-3) Transdifferentiates Fibroblasts Into Functional Endothelial Cells—Brief Report

  2019cites this paper
• Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate

  2019cites this paper
• Ex vivo Manufactured Neutrophils for Treatment of Neutropenia—A Process Economic Evaluation

  2019cites this paper
• Developing an induced pluripotent stem cell model of pulmonary arterial hypertension to understand the contribution of BMPR2 mutations to disease-associated phenotypes in smooth muscle cells

  2019cites this paper